The Application of the CRISPR-Cas System in Antibiotic Resistance
Shuan Tao,Huimin Chen,Na Li,Wei Liang
DOI: https://doi.org/10.2147/IDR.S370869
2022-08-02
Infection and Drug Resistance
Abstract:Shuan Tao, 1, 2 Huimin Chen, 1 Na Li, 3 Wei Liang 2 1 School of Medical, Jiangsu University, Zhenjiang, Jiangsu Province, 212013, People's Republic of China; 2 Lianyungang Clinical College of Jiangsu University, Lianyungang, Jiangsu Province, 222023, People's Republic of China; 3 Bengbu Medical College, Bengbu, Anhui Province, 233030, People's Republic of China Correspondence: Wei Liang, Lianyungang Clinical College of Jiangsu University, No. 161. Xingfu Road, Haizhou District, Lianyungang, Jiangsu Province, 222023, People's Republic of China, Tel/Fax +86-51885213100 ; Tel/Fax +86 15351883016, Email The emergence and global epidemic of antimicrobial resistance (AMR) poses a serious threat to global public health in recent years. AMR genes are shared between bacterial pathogens mainly via horizontal gene transfer (HGT) on mobile genetic elements (MGEs), thereby accelerating the spread of antimicrobial resistance (AMR) and increasing the burden of drug resistance. There is an urgent need to develop new strategies to control bacterial infections and the spread of antimicrobial resistance. The clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated proteins (Cas) are an RNA-guided adaptive immune system in prokaryotes that recognizes and defends against invasive genetic elements such as phages and plasmids. Because of its specifically target and cleave DNA sequences encoding antibiotic resistance genes, CRISPR/Cas system has been developed into a new gene-editing tool for the prevention and control of bacterial drug resistance. CRISPR-Cas plays a potentially important role in controlling horizontal gene transfer and limiting the spread of antibiotic resistance. In this review, we will introduce the structure and working mechanism of CRISPR-Cas systems, followed by delivery strategies, and then focus on the relationship between antimicrobial resistance and CRISPR-Cas. Moreover, the challenges and prospects of this research field are discussed, thereby providing a reference for the prevention and control of the spread of antibiotic resistance. Keywords: antibiotic resistance, CRISPR-Cas, horizontal gene transfer In recent years, antibiotic resistance has intensified due to the extensive use of antibiotics. 1 Antimicrobial resistance genes (ARGs) may be carried on the bacterial chromosome, and mobile genetic elements (MGEs) such as plasmid, and transposons. The resistance mechanisms mainly include the production of inactivated enzymes and modified enzymes (β-lactamases, aminoglycoside modifying enzymes), changes in the target site of the drug, the alteration of membrane permeability, increased active efflux pump system expression, formation of the bacterial biofilm (BBF). 2,3 BBF (adaptive resistance) serves as a diffusion barrier to limit the access of antibiotics to the bacterial cells. 4 Loss of efficacy in antibiotics due to antibiotic resistance in bacteria is an urgent threat to the success of microbial infection therapy. The spread of antibiotic-resistant bacteria poses a substantial threat to morbidity and mortality worldwide. 5,6 ARGs can spread through vertically inherited chromosomal mutations and horizontal gene transfer (HGT) mediated by MGEs among bacteria. 7 The acquisition of ARGs mediated by HGT is the main reason for the spread of drug resistance. 8 HGT is mainly driven by conjugation, transduction, and natural transformation. 9 MGEs share their genetic elements carrying resistance genes with other non-resistant bacterial species via HGT, which promoted the accumulation and dissemination of ARGs in Gram-negative and Gram-positive bacteria. 10,11 To treat bacterial infections and prevent and control the spread of antibiotic resistance, the research and development of new agents with therapeutic potential have attracted more attention worldwide. Bacteria have evolved multiple defense mechanisms under long-term selection pressure, such as restriction-modification systems and CRISPR-Cas system, which act as innate immune and adaptive systems in bacteria, and significantly affect the spread of antibiotic resistance genes and phage infection. 12–14 CRISPR-Cas systems are considered as barriers to HGT in bacteria. 15 CRISPR-Cas system can be used to re-sensitize drug-resistant bacteria to antibiotics by specifically eliminating the plasmids carrying antibiotic resistance genes. 16 CRISPR has been highlighted as an important tool to prevent and control the spread of bacterial resistance. In this review, we describe the structure and working mechanism of the CRISPR-Cas system, introduce the delivery method, elucidate the relationship between antimicrobial resistance and CRISPR- -Abstract Truncated-
pharmacology & pharmacy,infectious diseases